The trabecular bypass stent in a pseudophakic glaucoma patient: A 1-year follow-up

Glaucoma in pseudophakic eyes is not uncommon; both trabeculectomy and deep scle-rectomy failure have been reported in the literature with higher rates in pseudophakic eyes than in unoperated eyes (Fontana et al 2006). The iStent (Glaukos Corp, Laguna Hills, CA, USA) is a heparin-coated titanium device that can be inserted ab interno in the trabecular meshwork under gonioscopic control, driving the aqueous into the Schlemm’s canal; it can lower intraocular pressure (IOP) in cultured human anterior segments (Bahler et al 2004). The device inserted ab interno has shown to be clinically effective when used concomitantly with phacoemulsifi cation (Feijoo et al 2006). We report a case of a pseudophakic glaucoma patient who achieved target pressure after the implant of the trabecular bypass stent.